Skip to main content
. Author manuscript; available in PMC: 2022 Jul 6.
Published in final edited form as: Pract Radiat Oncol. 2012 May 3;3(1):e21–e28. doi: 10.1016/j.prro.2012.03.013

Table 3.

Treatment characteristics of patients experiencing grade 3–5 toxic effects after definitive radiotherapy for para-aortic recurrence

Grade of toxic effect Type of toxic effect Age, years Location of para-aortic recurrence GTV1 (cc) Prior Pelvic RT Surgical debulking Neoadjuvant or adjuvant chemotherapy Concurrent chemotherapy Maximum dose (Gy) / fraction no. Small bowel maximum / mean dose (Gy)
5 Duodenal fistula 59 L4–L5 31 No No Yes Cisplatin 66 / 30 64.3 / 21.5
4 Small bowel fistula 63 T12 2.6 No Yes No None 63 / 28 56.1 / 24.7
4 Small bowel perforation 54 L3–L4 15 No Yes Yes Cisplatin 63.8 / 29 69.0 / 26.0
4 Duodenal fistula 78 L3 17 Yes No Yes Cisplatin 61.6 / 28 61.1 / 23.5
3 Small bowel obstruction 53 L1–L2 10 Yes Yes Yes Cisplatin 64.12 / 28 65 / 16.2
1

GTV, gross tumor volume.